chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first 24 hours he had itching at his injection site/first 24 hours he had scratching at his injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (first 24 hours he had itching at his injection site/first 24 hours he had scratching at his injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (first 24 hours he had itching at his injection site/first 24 hours he had scratching at his injection site). At the time of the report, VACCINATION SITE PRURITUS (first 24 hours he had itching at his injection site/first 24 hours he had scratching at his injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was provided. No Treatment medication was reported.   Reporter did not allow further contact
revaccination with different covid vaccine; interchange of vaccine products; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 IMMUNISATION (revaccination with different covid vaccine) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products) in a 7-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect products included non-company products TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication and COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form, dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form and dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 IMMUNISATION (revaccination with different covid vaccine) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products). At the time of the report, COVID-19 IMMUNISATION (revaccination with different covid vaccine) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine products) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Mother or patient reports hives noted on child's face one hour after receiving vaccine. Advised 1 1/2 tsp BENADRYL (12.5mg/5ml). Will proceed to ER for any difficulty breathing. Parents did not administer BENADRYL or schedule recommended follow up in office.
Got flu like symptoms of headache and aches around body as well as sore throat and sinus congestion. Moderately severe, like a normal course of a bad cold. Starting to clear up by morning of 06/28.
Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy; Eyes and face started to swell up; Swelling under my eye; Welts on my face; Redness; Face was itching; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of DRUG INTERACTION (Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy), SWELLING FACE (Eyes and face started to swell up), EYE SWELLING (Swelling under my eye), PRURITUS (Face was itching) and URTICARIA (Welts on my face) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No past relevant history was given.  Concomitant products included HCTZ, SIMVASTATIN, SAW PALMETTO [SERENOA REPENS], CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]), COLECALCIFEROL (VITAMIN D 3), MAGNESIUM, METFORMIN, TAMSULOSIN and ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (Face was itching). On 09-Mar-2021, the patient experienced DRUG INTERACTION (Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy), SWELLING FACE (Eyes and face started to swell up), EYE SWELLING (Swelling under my eye), URTICARIA (Welts on my face) and ERYTHEMA (Redness). On 08-Mar-2021, PRURITUS (Face was itching) had resolved. On 10-Mar-2021, SWELLING FACE (Eyes and face started to swell up), URTICARIA (Welts on my face) and ERYTHEMA (Redness) had resolved. At the time of the report, DRUG INTERACTION (Not allergic to shrimp or the vaccination but I'm allergic to both of them together, combo allergy) outcome was unknown and EYE SWELLING (Swelling under my eye) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Shot in his hip (doesn't know the name).    Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-jun-2021 contains no new information.
Initial report was received from a consumer, who is also the patient on 27 December 2010. A 59 year-old female patient with no reported past medical history had received ADACEL (lot number, route and site of administration not reported) on 22 December 2010 and an unspecified amount of time later, experienced "severe eye pain - pain from eyes radiating through head with any eye movement", headache, arm pain and hand pain. The patient was not evaluated by a physician. Treatments included TYLENOL with some relief. The patient reports a decrease in eye and head pain but not totally gone. She also stated she is "getting better but very slowly". The patient's outcome was reported as unknown. Documents held by sender: none.
Information has been received from a physician concerning a 12 year old female who on 15-OCT-2007 was vaccinated with her first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) IM.  Concomitant therapy on 15-OCT-2007 included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid.  On 17-OCT-2007 the patient experienced hives all over her body.  The patient sought unspecified medical attention and her outcome is unknown.
Itchy, swollen lesion on arm beginning 1 week after vaccination. Started small and looked like a rash, the. grew to almost cover bicep in  2 days - no longer looking like a rash but a defined circular red lesion. Now, on the third day, the swelling has subsided and it is no longer itching, but is still slightly red.
During the 24-hour period after receiving the Pfizer bivalent vaccine on December 29, 2022, I began experiencing mild arm pain and stiffness, intermittent headaches, intermittent chills, nausea, fatigue, stiff painful joints, muscle pain, and nerve pain. I did not feel like I had a fever, so I did not take my temperature. The fatigue, joint pain, muscle pain and nerve pain were severe. Symptoms began to ease over the next 8 days, but the fatigue remained significant a lot of the time. I finally felt like I had turned a corner on December 7, although I was feeling very weak and weary because I had spent so much time in bed since my vaccination. However, a week later the fatigue returned, as did the intermittent chills and nausea. I took my temperature midday on January 15 and it was 100.6. I didn?t have a sore throat, abdominal pain, vomiting, diarrhea, cough or shortness of breath, but I took an at-home Covid test. It was negative. My temperature remained at 100.6 a few hours later, so I went to Urgent Care that evening. The doctor there tested me for influenza and UTI. Both were negative. My temperature at Urgent Care was 99.5. My temperature rose again to 100.6 later that night, but began to fall the following day. Since January 17, I haven?t had a fever and the fatigue also began to improve. By January 20, I felt pretty much back to normal.
Aug 20, 2022 developed sore throat, runny nose, fatigue. This progressed to extreme fatigue, upper respiratory congestion, cough, fever. Covid test positive Aug 24. Was unable to do test sooner since was on land tour.  I manages to push through most days, but fatigue and cough were problem. Unable to get paxlovid. Flew home  flew home overnight Aug 26 (don?t remember a lot about flight since I was asleep). Developed severe sinus pain and ear pain august 28. Had video visit with primary care on August 31. Still had bd cough but not SOB. Do with sinus infection. They don?t diagnose ear infections on video visits. Prescribed doxycycline and  Tessalon Perles. Saw dr ept 6 and still had upper respiratory symptoms and sever eustachuan dysfunction. Still severe fatigue.  He prescribed dose pack. Took about 2 more weeks to recover
Given expired flu injection. Expired 6/30/2020. No adverse reaction, normal outcome, patient is stable.
Hep B ( booster vaccine).  Right axillary swelling, and tenderness / Lymph nodes,  unable to put arm down.  on 8/21/ 22 swelling is going down.
Hot to the touch entire upper left arm  after first shot; Blotchy entire upper left arm  after first shot; Itching entire upper left arm  after first shot; Swollen entire upper left arm  after first shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to the touch entire upper left arm  after first shot), RASH MACULAR (Blotchy entire upper left arm  after first shot), VACCINATION SITE PRURITUS (Itching entire upper left arm  after first shot) and VACCINATION SITE SWELLING (Swollen entire upper left arm  after first shot) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Aug-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch entire upper left arm  after first shot), RASH MACULAR (Blotchy entire upper left arm  after first shot), VACCINATION SITE PRURITUS (Itching entire upper left arm  after first shot) and VACCINATION SITE SWELLING (Swollen entire upper left arm  after first shot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Injection site reaction, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Injection site reaction, at a dose of 1 dosage form. On 29-Aug-2021, VACCINATION SITE WARMTH (Hot to the touch entire upper left arm  after first shot), RASH MACULAR (Blotchy entire upper left arm  after first shot), VACCINATION SITE PRURITUS (Itching entire upper left arm  after first shot) and VACCINATION SITE SWELLING (Swollen entire upper left arm  after first shot) had resolved.            Concomitant medication was not provided. Treatment medication  was not provided .
- had shingles in past on the butt, re-appeared 4 days after shot. Both butt had shingles - improved since started.
gave expired vaccine to 2 patients; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave expired vaccine to 2 patients) and NO ADVERSE EVENT (no adverse event) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033c21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave expired vaccine to 2 patients) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (gave expired vaccine to 2 patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (gave expired vaccine to 2 patients).    No concomitant medication was reported. No treatment medication was reported.
With in 10 mins of receiving  1st dose, I started to feel hot and light headed, my body became very hot, I started to sweat and then my throat started to dry up and close. I notified the provider on watch that was monitoring me during my 15 mins after injection and as the walked me to the room I became more and more dizzy, my throat continued to swell and close, my mask was removed where my face was covered with a rash and hives . The dr. Gave me 50 mg benedryl, and a shot of epinephrine.  After wards 911 was called, my heart rate was eventually brought down with the epinephrine as my symptoms began to be controlled. An inhaler was administered because I was short of breath. 3 hours later I was stabilized. I then was recommended to go to urgent care rather the emergency room since the wait was 13 hours to be monitored at the local hospital MLK. I went to urgent care near my home at Hoag hospital and they monitored me and gave me a steroid injection IM. I was discharged with an epi pen just in case abs to take benedryl every 6 hours . The following morning 1/8/21, at 8 am the swelling of my throat retuned I became light headed abs my tongue became numb. I was taken to fountain valley hospital where an IV was started, 500 mg of iv benedryl, another epinephrine injection was given abs I remained under surveillance for another 6 hours. They stated that a lot of people are coming with reoccurring episodes of anaphylaxis after the phizer injection.
arm hurt for six months, and the patient didn´t take the other doses; arm hurt; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced pain in arm and incomplete course of vaccination. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient did not had shingles, but his/her doctor gave him/her a shot of Shingles vaccine because of his/her age and his/her arm hurt for 6 months. The patient stated that he/she would never take another shot. Till the time of reporting, the patient did not receive 2nd shot, which led to incomplete course of vaccination. The follow up would not be possible as no contact details were available.
Received injection at approximately 1330on 10/27/08, 3-4 hours later noticed sore L) arm.  At 2100 10/27/08, noted sore trapezium muscle and fatigue. Woke up on 10/28/08, noted to have enlarged and painful L) supraclavicular lymph node.  10/30/08 1345 came to Employee Health clinic after beling told by clinic doctor to go to employee health and have them report reaction.  Patient stated that suprclavicular lymph node is larger today than it was on 10/28 and with increase pain.
Fainted, convulsion type movements. About a 1 minute duration. Applied cold compresses, provided Sprite to patient, allowed to lie down until dizziness, pallor subsided.
Patient seen in office 2/5/2019 and describes persistent "stiffness" and difficulty moving  left arm using deltoid muscle. No discernable swelling or abnormality noted.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 06-NOV-2014, the patient was inoculated with ZOSTAVAX at a health care center/hospital as recommended for routine adult health maintenance and for the prevention of shingles (lot #, dose and route not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 24-JAN-2017 the patient was treated at a health care center/hospital for the onset of severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster. The patient was prescribed lidocaine and valacyclovir for management of his painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Symptoms began evening. Went to bed with chills and weakness. Awake at midnight with c/o headache and temp of 103.7. Rapid heartbeat per mother.
Developed cellulitis, Patient was treated with IV Vancomycin, Clindamycin, ANCEF. Patient's cellulitis is resolving.
Information has been received from a healthcare worker (a certified medical assistant) referring to an unspecified number of patients of unknown age and gender. No concurrent conditions, medical history or drug allergies were reported. On 18-JUN-2015, the patients were vaccinated with improperly stored PROQUAD (Merck) (lot# also reported L005297 with expired date 17-AUG-2016) (dosing regimen and route unknown). No concomitant medications were provided. No adverse effects were reported. Lot verification result has been received on 10-JUL-2015 and lot number L005297 with an expiry date of 17-AUG-2016 has been validated for PROQUAD (Merck). All telephone attempts to obtain follow-up information on 03-AUG-2015 have been unsuccessful. Follow-up information has been received from a telephone call on 05-AUG-2015. The Certified Medical Assistant reported that she would have to research the request made for patient identifiers, lot number, expiration date and dates of vaccination. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015, regarding a 4-year-old patient of unknown gender. On 20-JUL-2015, the patient was vaccinated with a dose of PROQUAD (Merck) Lot # was confirmed to be L005297. This is one of several reports received from the same reporter. Additional information has been requested. Patient's details, product, event information and narrative were updated.
Dizziness, Headache, NauseaVomiting, muscle weakness, fatigue, nausea (no vomiting), increased sinus drainage Narrative:
Fever up to 105.7 for 5 days (starting 6-7 hours after injections), ended up diagnosed with primary HSV outbreak. Recieved influenza, Menactra and Tdap that day.
Red, painful, and hot at injection site for three days starting the morning of 5/4/2019.  Also, beginning the morning of 5/4/2019 and lasting one day:  extreme fatigue, achy muscles, slight fever, light headedness, headache.
On 12/27/2022, I started feeling sick with flu like symptoms. I took a Sudafed PE and around 02:00PM, I took an at home COVID-19 test which was positive. At that point, my heartbeat went up to 150 and my blood pressure was down to 65. I was admitted to the local hospital. They confirmed my COVID-19 diagnosis and admitted me for 2 days. I was given medication for COVID-19. They also took me off of Amlodipine and prescribed Metoprolol. I started feeling back to normal by 12/30/2022, after leaving the hospital.
Chills; suck for a couple of days/ achey/ had the same reaction.; Cold; This case was reported by a consumer interactive digital media and described the occurrence of chills in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of nasopharyngitis (along with cough and aches after receiving1st dose on an unknown date, for tolerance refer case US2021AMR156018).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced chills, pain and cold. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the chills, pain and cold were unknown.   It was unknown if the reporter considered the chills, pain and cold to be related to Shingles vaccine.  Additional details were reported as follows: Additional details were provided are as follows: The age at vaccination was not reported. The patient self reported the case. The patient stated that, the shots were good but also suck for a couple of days when first get them. After the 2nd shot which was due several weeks later, the patient had the same reaction as like 1st shot including cold, chills and was achy; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR156018:Same reporter
It started with mild symptoms, headache, cough and chills.  Over there first night I developed a fever starting at 100 and by early morning rose to 101/102.  It was the following day 04/12/2021 I felt that I had frequent arrhythmia more so than normal along with the moderate flu symptoms aforementioned.  I then decided to call the school and they had suggested I a take a Covid test as it may have been Covid when I had not been knowingly exposed to anyone in the prior days.   I took a test and was negative.  It was my heart symptoms that concerned me most.
Information has been received from a Licensed Practical Nurse referring to a patient of unknown age and gender. There was no pertinent medical history or drug reaction/allergies reported. On 10-JUL-2015 the patient was inadvertently administered with a dose of expired M-M-R II (lot # J007930, expired date 28-JUN-2015, dose and route were unknown). No adverse effects were reported. Additional information has been requested.
This case was reported by a nurse via sales rep and described the occurrence of rash in a 53-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on unknown date). On 22nd October 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced rash and pain in arm. On an unknown date, the outcome of the rash and pain in arm were recovered/resolved. It was unknown if the reporter considered the rash and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The patient received a dose of SHINGRIX on an unknown arm. The events were lasted for 3 days. The reporter had given permission to follow up.